Clinical relevance:Incretin-based therapies are revolutionizing the field of human diabetes mellitus (DM) by replacing insulin therapy with safer and more convenient long-acting drugs.Mechanism of action:Incretin hormones (glucagon-like peptide-1 [GLP-1] …